Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination
16 mars 2021 03h30 HE
|
Immunicum AB
Press Release 16 March 2021 Immunicum AB (publ) Announces Updated Executive Management Team After Business Combination Immunicum AB (publ; IMMU.ST) announced today the establishment of an updated...
Immunicum AB (publ) meddelar att Jeroen Rovers har utsetts till medicinsk chef
01 mars 2021 02h00 HE
|
Immunicum AB
Pressmeddelande 1 mars 2021 Immunicum AB (publ) meddelar att Jeroen Rovers har utsetts till medicinsk chef Immunicum AB (publ; IMMU.ST) meddelar idag att Jeroen Rovers, M.D., Ph.D. har utsetts...
Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief Medical Officer
01 mars 2021 02h00 HE
|
Immunicum AB
Press Release 1 March 2021 Immunicum AB (publ) Announces Appointment of Jeroen Rovers as Chief Medical Officer Immunicum AB (publ; IMMU.ST) announced today that Jeroen Rovers, M.D., Ph.D., has...
Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer
22 févr. 2021 02h00 HE
|
Immunicum AB
Pressmeddelande 22 februari 2021 Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer - Medianöverlevnad för patientgruppen som behandlades...
Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer
22 févr. 2021 02h00 HE
|
Immunicum AB
Press Release 22 February 2021 Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer -- Median Overall Survival (OS) for the...
Immunicum AB (publ) publicerar bokslutskommuniké 2020
18 févr. 2021 02h00 HE
|
Immunicum AB
Pressmeddelande 18 februari 2021 Immunicum AB (publ) publicerar bokslutskommuniké 2020 OKTOBER - DECEMER I SAMMANDRAG Nettoomsättning för kvartalet uppgick till - (-)*.Periodens resultat...
Immunicum AB (publ) Announces Year-End Results 2020
18 févr. 2021 02h00 HE
|
Immunicum AB
Press Release 18 February 2021 Immunicum AB (publ) Announces Year-End Results 2020 OCTOBER-DECEMBER IN SUMMARY Net sales for the period amounted to KSEK – (-)*.Result for the...
LEADING EDGE MATERIALS SIGNS DEFINITIVE AGREEMENT TO SELL 100% OF THE BERGBY LITHIUM PROJECT
11 févr. 2021 09h15 HE
|
Leading Edge Materials Corp.
Vancouver, February 11, 2021 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) is pleased to announce it has signed a...
Immunicum AB (publ) meddelar att Lotta Ferm har utsetts till ny tillförordnad finanschef
01 févr. 2021 11h45 HE
|
Immunicum AB
Pressmeddelande 1 februari 2021 Immunicum AB (publ) meddelar att Lotta Ferm har utsetts till ny tillförordnad finanschef Immunicum AB (publ; IMMU.ST) meddelar idag att Lotta Ferm kommer att...
Immunicum AB (publ) Announces New Interim CFO Lotta Ferm
01 févr. 2021 11h45 HE
|
Immunicum AB
Press Release 01 February 2021 Immunicum AB (publ) Announces New Interim CFO Lotta Ferm Immunicum AB (publ; IMMU.ST) announced today that effective immediately, Lotta Ferm will join the leadership...